Immunotope Diagnostics Inc is a clinical stage biotechnology company based in Doylestown, PA, specializing in the development of immunotherapy products for the treatment and prevention of cancer and chronic viral infections. Their comprehensive approach to cancer therapy focuses on early diagnosis and the development of effective treatments that destroy tumors and prevent metastasis.
Utilizing proprietary immunoproteomics technologies, Immunotope identifies naturally processed and presented antigens associated with diseased cells, activating the patient's own immune system to fight disease and prevent recurrence. With a product portfolio that includes ovarian, breast, prostate, lung, pancreatic, and colon cancer, Immunotope aims to provide highly efficacious, curative treatments with minimal toxicity, while also offering innovative tools and services for collaborative development of novel drug and diagnostic products.
Generated from the website